Autoimmunity: Does autoantigen complementarity underlie PR3-ANCA AAV?

Nature Reviews Rheumatology

Volumn 7, Issue 8, 2011, Pages 439-440

  Preston, Gloria ^a   Falk, Ronald ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; AUTOANTIGEN; GLUTAMATE DECARBOXYLASE 65 ANTIBODY; HLA DR ANTIGEN; IDIOTYPIC ANTIBODY; IMMUNOGLOBULIN G; LA ANTIBODY; MYELOBLASTIN; NEUTROPHIL CYTOPLASMIC ANTIBODY;

AMINO ACID SEQUENCE; ANCA ASSOCIATED VASCULITIS; ANTIGEN PRESENTING CELL; AUTOIMMUNITY; BINDING AFFINITY; BINDING SITE; GENE FREQUENCY; HUMAN; IMMUNOPATHOGENESIS; IMMUNOREACTIVITY; MEMORY T LYMPHOCYTE; PRIORITY JOURNAL; SHORT SURVEY; T LYMPHOCYTE ACTIVATION;

ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; AUTOANTIGENS; AUTOIMMUNITY; HUMANS; MYELOBLASTIN;

EID: 80051473438     PISSN: 17594790     EISSN: 17594804     Source Type: Journal    
DOI: 10.1038/nrrheum.2011.86     Document Type: Short Survey

References (10)

1. Tadema, H., Kallenberg, C. G., Stegeman, C. A. & Heeringa, P. Reactivity against complementary proteinase-3 is not increased in patients with PR3-ANCA -Associated vasculitis. PLoS ONE 6, e17972 (2011).
2. Mekler, L. B. Specific selective interaction between amino acid groups of polypeptide chains [Russian]. Biofizika 14, 581-584 (1969).
3. Blalock, J. E. Complementarity of peptides specified by 'sense' and 'antisense' strands of DNA. Trends Biotechnol. 8, 140-144 (1990). (Pubitemid 20175423)
4. Pendergraft, W. F. III. et al. Autoimmunity is triggered by cPR-3(105-201), a protein complementary to human autoantigen proteinase-3. Nat. Med. 10, 72-79 (2004). (Pubitemid 38524701)
5. Cao, Y. et al. DRB1*15 allele is a risk factor for PR-3 ANCA disease in African Americans. J. Am. Soc. Nephrol. (in press).
6. Hewins, P., Belmonte, F., Charles Jennette, J., Falk, R. J. & Preston, G. A. Longitudinal studies of patients with ANCA vasculitis demonstrate concurrent reactivity to complementary PR3 protein segments cPR3m and cPR3C and with no reactivity to cPR3N. Autoimmunity 44, 98-106 (2011).
7. Bautz, D. J. et al. Antibodies with dual reactivity to plasminogen and complementary PR3 in PR3-ANCA vasculitis. J. Am. Soc. Nephrol. 19, 2421-2429 (2008).
8. Oak, S., Radtke, J., Törn, C., Landin-Olsson, M. & Hampe, C. S. Immunoglobulin subclass profiles of anti-idiotypic antibodies to GAD65Ab differ between type 1 diabetes patients and healthy individuals. Scand. J. Immunol. doi:10.1111/j.1365-30832011.02565.x.
9. Routsias, J. G. et al. Unmasking the anti-La/SSB response in sera from patients with Sjögren's syndrome by specific blocking of anti-idiotypic antibodies to La/SSB antigenic determinants. Mol. Med. 8, 293-305 (2002).
10. Tzioufas, A. G. & Routsias, J. G. Idiotype, anti-idiotype network of autoantibodies: Pathogenetic considerations and clinical application. Autoimmun. Rev. 9, 631-633 (2010).